(Q48467191)

English

Deprenyl decreases an endogenous parkinsonism-inducing compound, 1-benzyl-1,2,3,4-tetrahydroisoquinoline in mice: in vivo and in vitro studies

scientific article published in March 1998

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9518683

Deprenyl decreases an endogenous parkinsonism-inducing compound, 1-benzyl-1,2,3,4-tetrahydroisoquinoline in mice: in vivo and in vitro studies (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9518683

Parkinson's disease

1 reference

based on heuristic

inferred from title

author name string

Kotake Y

1

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9518683

Tasaki Y

2

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9518683

Hirobe M

3

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9518683

Ohta S

4

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9518683

language of work or name

0 references

publication date

1 March 1998

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9518683

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9518683

787

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9518683

2

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9518683

341-343

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9518683

Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901560-6

7 January 2021

The molecular pharmacology of L-deprenyl

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901560-6

7 January 2021

Tetrahydroisoquinoline and 1-methyl-tetrahydroisoquinoline as novel endogenous amines in rat brain

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901560-6

7 January 2021

1‐Benzyl‐1,2,3,4‐Tetrahydroisoquinoline as a Parkinsonism‐Inducing Agent: A Novel Endogenous Amine in Mouse Brain and Parkinsonian CSF

2 references

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901560-6

7 January 2021

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901560-6

7 January 2021

based on heuristic

inferred from DOI database lookup

Chronic administration of 1-benzyl-1,2,3,4-tetrahydroisoquinoline, an endogenous amine in the brain, induces parkinsonism in a primate

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901560-6

7 January 2021

beta-Carbolinium cations, endogenous MPP+ analogs, in the lumbar cerebrospinal fluid of patients with Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901560-6

7 January 2021

Differences in dopamine efflux induced by MPP+ and beta-carbolinium in the striatum of conscious rats

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901560-6

7 January 2021

Effect of deprenyl on the progression of disability in early Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901560-6

7 January 2021

DATATOP: a multicenter controlled clinical trial in early Parkinson's disease. Parkinson Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901560-6

7 January 2021

The effect of monoamine oxidase inhibitors on some arylalkylamines in rate striatum

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901560-6

7 January 2021

Monoamine oxidase activity and monoamine metabolism in brains of parkinsonian patients treated with l-deprenyl

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901560-6

7 January 2021

The effects of monoamine oxidase B inhibition on dopamine metabolism in rats with nigro-striatal lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901560-6

7 January 2021

1-Methyl-1,2,3,4-tetrahydroisoquinoline, decreasing in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse, prevents parkinsonism-like behavior abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901560-6

7 January 2021

Antioxidant mechanism and protection of nigral neurons against MPP+ toxicity by deprenyl (selegiline).

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901560-6

7 January 2021

Isolation of 1-methyl-1,2,3,4-tetrahydroisoquinoline-synthesizing enzyme from rat brain: a possible Parkinson's disease-preventing enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901560-6

7 January 2021

The relevance of glial monoamine oxidase-B and polyamines to the action of selegiline in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1016%2FS0006-8993%2897%2901560-6

7 January 2021

Identifiers

10.1016/S0006-8993(97)01560-6

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9518683

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 February 2018

http://europepmc.org/abstract/MED/9518683

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q48467191&oldid=2199644130"